documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

74 rows where agency_id = "FDA", document_type = "Other" and posted_year = 1996 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: docket_id, subtype, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 1

  • 1996 · 74 ✖

document_type 1

  • Other · 74 ✖

agency_id 1

  • FDA · 74 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1996-P-0042-0001 FDA Require generic clonazepam prods meet the same dissolution q FDA-1996-P-0042 Acknowledgement Letter from FDA DMB to Hoffmann-La Roche, Inc Other ACK-Acknowledgement Letter 1996-12-26T05:00:00Z 1996 12     2024-07-20T18:43:52Z   0 0 09000064804fc613
FDA-1996-P-0016-0007 FDA Amend 'Healthy' Definition re: Sodium Levels FDA-1996-P-0016 HFA-305 to ConAgra, Inc. Other ACK-Acknowledgement Letter 1996-12-23T05:00:00Z 1996 12     2008-05-16T22:19:43Z   0 0 09000064804fa34c
FDA-1995-S-0039-0027 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report (outside of agency unless indicated) 1996-12-17T05:00:00Z 1996 12 2008-09-28T04:00:00Z   2016-09-30T14:19:46Z   0 0 090000648055c2e4
FDA-1995-S-0039-0019 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report 1996-12-12T05:00:00Z 1996 12 2008-09-28T04:00:00Z   2016-09-30T14:19:41Z   0 0 090000648055c2e2
FDA-1978-N-0018-0425 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Letter from FDA CDER to Johnson & Johnson Consumer Products, Inc. Other Letter(s) 1996-11-15T05:00:00Z 1996 11     2019-08-28T12:39:34Z   0 0 090000648055a5d5
FDA-1996-P-0015-0002 FDA Bioequivalence Req. for Asacol Delayed-Release Tablets-CLOSED FDA-1996-P-0015 Acknowledgment Letter from FDA DMB to Procter & Gamble Pharmaceuticals Other Acknowledgement Letter/Receipt 1996-11-06T05:00:00Z 1996 11     2024-12-18T21:48:26Z   0 0 09000064804f9d67
FDA-1996-A-0054-0002 FDA Eastlon PET Staple Fiber Complies with Applicable Regulations; Appropriate for Safe Use FDA-1996-A-0054 Advisory Opinion Denial Response Letter from FDA ORA to Far Eastern Textile Ltd. Other Denial 1996-11-01T05:00:00Z 1996 11     2018-03-19T16:29:34Z   0 0 09000064804fd2d9
FDA-1996-A-0054-0003 FDA Eastlon PET Staple Fiber Complies with Applicable Regulations; Appropriate for Safe Use FDA-1996-A-0054 Advisory Opinion Denial Response Letter from FDA ORA to Far Eastern Textile Ltd. Other Denial 1996-11-01T05:00:00Z 1996 11     2024-07-01T19:37:18Z   0 0 09000064804fd2da
FDA-1996-A-0054-0001 FDA Eastlon PET Staple Fiber Complies with Applicable Regulations; Appropriate for Safe Use FDA-1996-A-0054 Advisory Opinion Denial Response Letter from FDA ORA to Far Eastern Textile Ltd. Other Denial 1996-11-01T05:00:00Z 1996 11     2024-07-01T19:36:53Z   0 0 09000064804fd2d3
FDA-1996-P-0015-0001 FDA Bioequivalence Req. for Asacol Delayed-Release Tablets-CLOSED FDA-1996-P-0015 Acknowledgment Letter from FDA DMB to Procter & Gamble Pharmaceuticals Other Acknowledgement Letter/Receipt 1996-10-31T05:00:00Z 1996 10     2024-12-18T21:44:30Z   0 0 09000064804f9cd0
FDA-1996-V-0017-0002 FDA Variance for High Light Laser System Model K333 FDA-1996-V-0017 Acknowledgement Letter to TriLasers Other ACK-Acknowledgement Letter 1996-10-18T04:00:00Z 1996 10     2008-10-30T14:11:12Z   0 0 09000064804fa476
FDA-1978-N-0018-0424 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Transcript of Public Meeting to Discuss the Photochemistry and Photobiology of Sunscreen, Thursday, September 19, 1996 8:30 a.m., pgs. 1-100 (Vol. 1 of 3) Other Transcript(s) 1996-10-16T04:00:00Z 1996 10     2019-07-26T17:57:30Z   0 0 090000648055a5c8
FDA-1996-P-0309-0005 FDA Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 Supplement from Andes Candies, Inc., Nutrition Research Group (NRG) Other Supplement (SUP) 1996-10-16T04:00:00Z 1996 10 2014-02-20T05:00:00Z   2014-02-20T12:05:16Z   0 0 0900006480504c77
FDA-1980-N-0074-0049 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association Other LET-Letter 1996-10-15T04:00:00Z 1996 10     2022-05-09T20:53:16Z   0 0 09000064805bb476
FDA-1980-N-0074-0050 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association Other Letter(s) 1996-10-15T04:00:00Z 1996 10     2022-05-10T18:15:02Z   0 0 09000064805bb477
FDA-1980-N-0074-0047 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Letter from FDA HFD-560 to Jane Baluss-Buc & Beardsley Other Letter(s) 1996-10-07T04:00:00Z 1996 10     2022-05-09T20:12:01Z   0 0 09000064805bb474
FDA-1996-P-0246-0004 FDA Establishes RACCs for Various Types of Food Products Candies FDA-1996-P-0246 Supplement from Chocolate Manufacturers Association (CMA) and National Confectioners Association (NCA) Other Supplement (SUP) 1996-10-02T04:00:00Z 1996 10 2014-02-20T05:00:00Z   2014-02-20T13:40:29Z   0 0 0900006480503973
FDA-1996-P-0021-0001 FDA ANDA for a delayed-release cap. of Diclofenac Sodium 50 mg.-CLOSED FDA-1996-P-0021 Acknowledgement Letter from FDA/DMB to Carlsbad Technology, Inc. Other Acknowledgement Letter/Receipt 1996-10-02T04:00:00Z 1996 10     2024-12-13T21:54:42Z   0 0 09000064804fa6c2
FDA-1996-P-0020-0001 FDA Beconase AQ Metered Nasal Spray, 0.042mg/INH-CLOSED FDA-1996-P-0020 Acknowledgment Letter from FDA DMB to Lachman Consultant Services, Inc. Other Acknowledgement Letter/Receipt 1996-09-23T04:00:00Z 1996 9     2024-12-16T18:35:01Z   0 0 09000064804fa5af
FDA-1996-P-0031-0002 FDA Consider solid oral dosage form drug products as same dosage-CLOSED FDA-1996-P-0031 HFA-305 to National Assn. of Pharmaceutical Manufacturers Other ACK-Acknowledgement Letter 1996-09-05T04:00:00Z 1996 9     2008-05-16T22:20:07Z   0 0 09000064804fc448
FDA-1994-P-0013-0005 FDA Reference Amount of Wild Rice-CLOSED FDA-1994-P-0013 Memorandum Other Memorandum 1996-08-22T04:00:00Z 1996 8     2024-06-27T03:38:11Z   0 0 09000064804fc7df
FDA-1994-P-0013-0006 FDA Reference Amount of Wild Rice-CLOSED FDA-1994-P-0013 Memorandum of Meeting Other Memorandum 1996-08-22T04:00:00Z 1996 8     2024-06-27T03:40:07Z   0 0 09000064804fc7e0
FDA-1995-S-0039-0018 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report 1996-08-12T04:00:00Z 1996 8 2008-09-28T04:00:00Z   2016-09-30T14:19:41Z   0 0 090000648055c2c5
FDA-1996-P-0001-0001 FDA Establish the in Vivo Bioequival. Requirem. for Hetastarch-CLOSED FDA-1996-P-0001 Petition denial from FDA CDER to McGaw Inc Other Denial 1996-08-09T04:00:00Z 1996 8     2024-06-06T01:00:27Z   0 0 09000064804f98b8
FDA-1978-N-0018-0152 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Answer Letter from FDA CDER to King and Spalding Other Answer 1996-08-02T04:00:00Z 1996 8     2019-07-24T13:17:19Z   0 0 090000648055a301
FDA-1978-N-0018-0151 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Letter from FDA CDER to Vital Technologies Corporation Other Letter(s) 1996-08-01T04:00:00Z 1996 8     2019-07-24T13:10:00Z   0 0 090000648055a2ff
FDA-1994-P-0013-0004 FDA Reference Amount of Wild Rice-CLOSED FDA-1994-P-0013 Routing and Transmittal Slip Other Memorandum 1996-07-25T04:00:00Z 1996 7     2024-06-27T03:35:48Z   0 0 09000064804fc7dd
FDA-1994-P-0013-0003 FDA Reference Amount of Wild Rice-CLOSED FDA-1994-P-0013 Memo of Meeting FDA CFSAN and University of Minnesota Other Memorandum 1996-07-25T04:00:00Z 1996 7     2024-06-27T03:33:06Z   0 0 09000064804fc7dc
FDA-1978-N-0018-0150 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Letter from FDA CDER to H. Gordon Ainsleigh, D. C. Other Letter(s) 1996-07-09T04:00:00Z 1996 7     2019-07-24T13:04:25Z   0 0 090000648055a2fd
FDA-1996-P-0309-0004 FDA Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 Interim Response Letter from FDA/CFSAN to Andes Candies, Inc., Nutrition Research Group (NRG) Other Letter(s) 1996-07-03T04:00:00Z 1996 7 2014-02-20T05:00:00Z   2014-02-20T12:01:49Z   0 0 0900006480504c75
FDA-1977-N-0023-0002 FDA Internal analgesic, antipyretic & antirheumatic drug - OPEN FDA-1977-N-0023 Internal Memorandum from Valerie J. Miguele (HFD-560) to FDA DDM (HFA-305) June 17, 1996 Other Memorandum 1996-07-02T04:00:00Z 1996 7     2019-02-13T14:22:59Z   0 0 09000064805da1b5
FDA-1980-N-0074-0044 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association Other Letter(s) 1996-07-01T04:00:00Z 1996 7     2022-05-02T20:09:11Z   0 0 09000064805bb462
FDA-1980-N-0074-0045 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association Other Letter(s) 1996-07-01T04:00:00Z 1996 7     2022-05-02T20:12:18Z   0 0 09000064805bb463
FDA-1980-N-0074-0046 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association Other Letter(s) 1996-07-01T04:00:00Z 1996 7     2022-05-02T20:15:21Z   0 0 09000064805bb464
FDA-1996-V-0036-0006 FDA Variance for Laser Light Show FDA-1996-V-0036 Acknowledgement Letter to Lasersmith Light Show System Other ACK-Acknowledgement Letter 1996-06-25T04:00:00Z 1996 6     2013-07-27T21:18:26Z   0 0 09000064804fc519
FDA-1996-P-0002-0002 FDA ANDA for selegiline hydrochloride tablets 5 mg FDA-1996-P-0002 Acknowledgment letter from FDA DMB to Novopharm Limited Other ACK-Acknowledgement Letter 1996-06-12T04:00:00Z 1996 6     2024-06-18T17:37:54Z   0 0 09000064804f98d2
FDA-1980-N-0074-0042 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association Other Letter(s) 1996-06-04T04:00:00Z 1996 6     2022-05-02T16:45:51Z   0 0 09000064805bb45f
FDA-1980-N-0074-0043 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association Other Letter(s) 1996-06-04T04:00:00Z 1996 6     2022-05-02T16:48:45Z   0 0 09000064805bb460
FDA-1996-P-0246-0002 FDA Establishes RACCs for Various Types of Food Products Candies FDA-1996-P-0246 Acknowledgement Letter to Chocolate Manufacturers Association (CMA) and National Confectioners Association (NCA) Other Acknowledgement Letter/Receipt 1996-06-03T04:00:00Z 1996 6 2014-02-20T05:00:00Z   2014-02-20T13:34:56Z   0 0 0900006481259ae8
FDA-1995-N-0062-0006 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA OLA to Comment from the Honorable David R. Obey, United States House of Representatives Other Answer 1996-06-03T04:00:00Z 1996 6     2020-01-13T13:23:38Z   0 0 090000648056c8f6
FDA-1996-P-0246-0001 FDA Establishes RACCs for Various Types of Food Products Candies FDA-1996-P-0246 Citizen Petition from Chocolate Manufacturers Association (CMA) and National Confectioners Association (NCA) Other Citizen Petition 1996-05-31T04:00:00Z 1996 5 1996-05-31T04:00:00Z   2014-02-20T18:42:14Z   0 0 0900006480503971
FDA-1978-N-0018-0147 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Response Letter from FDA CDER to Edward Basile, King and Spalding Other Letter(s) 1996-05-21T04:00:00Z 1996 5     2019-07-23T20:43:00Z   0 0 090000648055a2f0
FDA-1996-P-0041-0002 FDA Refrain from granting exclusivity to NDAs for Fexofenadine FDA-1996-P-0041 Acknowledgement Letter from FDA/DMB to Olsson, Frank & Weeda, P.C. Other Acknowledgement Letter/Receipt 1996-05-21T04:00:00Z 1996 5     2024-06-20T14:50:00Z   0 0 09000064804fc604
FDA-1978-N-0018-0149 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Letter from FDA CDER to Schering-Plough HealthCare Products Other Letter(s) 1996-05-21T04:00:00Z 1996 5     2019-07-24T12:52:08Z   0 0 090000648055a2f8
FDA-1978-N-0018-0148 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Response Letter from FDA CDER to Edward Basile, King and Spalding Other Letter(s) 1996-05-21T04:00:00Z 1996 5     2019-08-30T20:09:14Z   0 0 090000648055a2f4
FDA-1980-N-0074-0041 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Letter from FDA HFD-560 to American Dental Association Other Letter(s) 1996-05-20T04:00:00Z 1996 5     2022-05-02T16:30:46Z   0 0 09000064805bb45d
FDA-1978-N-0018-0146 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Letter from FDA CDER to TIOXIDE Specialties, Ltd. Other Letter(s) 1996-05-16T04:00:00Z 1996 5     2019-07-23T20:10:09Z   0 0 090000648055a2e5
FDA-1978-N-0018-0145 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Letter from FDA CDER to H. Gordon Ainsleigh, D. C. Other Letter(s) 1996-05-13T04:00:00Z 1996 5     2019-07-23T20:00:08Z   0 0 090000648055a2e2
FDA-1995-S-0039-0016 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report (outside of agency unless indicated) 1996-05-07T04:00:00Z 1996 5 2008-09-28T04:00:00Z   2016-09-30T14:19:39Z   0 0 090000648055c2be
FDA-1996-P-0032-0001 FDA Establishing a Daily Reference Value DRV for Chloride FDA-1996-P-0032 Acknowledgement letter from FDA DMB to Mead Johnson & Company Other Acknowledgement Letter/Receipt 1996-05-01T04:00:00Z 1996 5     2024-06-15T01:00:35Z   0 0 09000064804fc468
FDA-1980-N-0074-0040 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Acknowledgement Letter to Nonprescription Drug Manufacturers Association & CTFA (4/18/96) Other ACK-Acknowledgement Letter 1996-04-18T04:00:00Z 1996 4     2009-03-26T20:38:33Z   0 0 09000064805bb3f2
FDA-1980-N-0074-0038 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Acknowledgement Letter to Nonprescription Drug Manufacturers Association & CTFA (4/18/96) Other ACK-Acknowledgement Letter 1996-04-18T04:00:00Z 1996 4     2009-03-26T20:31:30Z   0 0 09000064805bb3ee
FDA-1980-N-0074-0039 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Acknowledgement to Nonprescription Drug Manufacturers Association & CFTA (4/18/96) Other ACK-Acknowledgement Letter 1996-04-18T04:00:00Z 1996 4     2009-03-26T20:35:23Z   0 0 09000064805bb3f0
FDA-1980-N-0074-0037 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Acknowledgement Letter to Nonprescription Drug Manufacturers Association & CTFA (4/18/96) Other ACK-Acknowledgement Letter 1996-04-18T04:00:00Z 1996 4     2009-03-26T18:45:27Z   0 0 09000064805bb3dc
FDA-1995-S-0039-0013 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report (outside of agency unless indicated) 1996-04-16T04:00:00Z 1996 4 2008-09-28T04:00:00Z   2016-09-30T14:19:38Z   0 0 090000648055c275
FDA-1993-P-0054-0001 FDA Amend the Reference Amount for Anchovies at 5 grams-CLOSED FDA-1993-P-0054 HFD-1 to Association of Food Industries Inc Other PDN-Petition Denial 1996-04-08T04:00:00Z 1996 4     2008-05-16T23:29:19Z   0 0 09000064804fc5ea
FDA-1996-P-0035-0001 FDA To Accurately Communicate Scientific Fact That Stearic Acid; CLOSED 02/03/2020 FDA-1996-P-0035 Acknowledgement Letter to American Cocoa Research Institute Other Acknowledgement Letter/Receipt 1996-04-04T05:00:00Z 1996 4 1996-04-04T05:00:00Z   2013-07-27T21:18:24Z   0 0 09000064804fc4c2
FDA-1995-N-0062-0012 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from The Honorable Rick Santorum, United States Senate Other Answer 1996-03-20T05:00:00Z 1996 3     2020-01-09T17:34:40Z   0 0 090000648056c902
FDA-1995-N-0062-0011 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from The Honorable Dianne Feinstein, United States Senate Other Answer 1996-03-18T05:00:00Z 1996 3     2020-01-09T17:14:13Z   0 0 090000648056c900
FDA-1995-N-0062-0010 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from The Honorable Phil English, United States House of Representatives Other Answer 1996-03-08T05:00:00Z 1996 3     2020-01-09T16:59:40Z   0 0 090000648056c8fd
FDA-1995-N-0062-0009 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from The Honorable Thomas E. Petri, United States House of Representatives Other Answer 1996-03-06T05:00:00Z 1996 3     2020-01-09T16:48:44Z   0 0 090000648056c8fb
FDA-1995-N-0062-0008 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from The Honorable Arlen Specter, United States Senate Other Answer 1996-03-06T05:00:00Z 1996 3     2020-01-09T16:27:40Z   0 0 090000648056c8fa
FDA-1995-S-0039-0017 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report (outside of agency unless indicated) 1996-03-04T05:00:00Z 1996 3 2008-09-28T04:00:00Z   2016-09-30T14:19:40Z   0 0 090000648055c2c1
FDA-1995-N-0062-0007 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from The Honorable Frank D. Lucas, United States House of Representatives Other Answer 1996-02-28T05:00:00Z 1996 2     2020-01-09T16:12:10Z   0 0 090000648056c8f8
FDA-1996-A-0054-0004 FDA Eastlon PET Staple Fiber Complies with Applicable Regulations; Appropriate for Safe Use FDA-1996-A-0054 Acknowledgment Letter from FDA DDM to Far Eastern Textile Ltd. Other Acknowledgement Letter/Receipt 1996-02-27T05:00:00Z 1996 2     2018-03-19T16:35:42Z   0 0 09000064804fd2db
FDA-1996-P-0309-0003 FDA Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 Amendment from Andes Candies, Inc. Nutrition Research Group (NRG) Other Amendment 1996-02-21T05:00:00Z 1996 2 2014-02-20T05:00:00Z   2014-02-20T12:06:41Z   0 0 0900006480504c73
FDA-1995-N-0062-0005 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from The Kroger Co. Other Answer 1996-02-20T05:00:00Z 1996 2     2020-01-10T14:03:04Z   0 0 090000648056c8f4
FDA-1995-N-0062-0004 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from The Honorable James M. Inhofe, United States Senate Other Answer 1996-02-20T05:00:00Z 1996 2     2020-01-10T13:52:23Z   0 0 090000648056c8f2
FDA-1980-N-0074-0036 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 Acknowledgement Letter to Tom's of Maine (2/20/96) Other ACK-Acknowledgement Letter 1996-02-20T05:00:00Z 1996 2     2009-03-26T18:41:20Z   0 0 09000064805bb3d6
FDA-1996-P-0047-0001 FDA Refrain from granting exclusivity for Minoxidil, Rogaine-CLOSED FDA-1996-P-0047 Acknowledgement Letter from FDA HFA-305 to Olsson, Frank & Weeda, P.C Other Acknowledgement Letter/Receipt 1996-02-09T05:00:00Z 1996 2     2022-08-22T18:42:28Z   0 0 09000064804fc779
FDA-1996-P-0001-0002 FDA Establish the in Vivo Bioequival. Requirem. for Hetastarch-CLOSED FDA-1996-P-0001 Acknowledgement Letter from FDA DMB to McGaw Inc. Other Acknowledgement Letter/Receipt 1996-01-31T05:00:00Z 1996 1     2024-06-05T14:24:53Z   0 0 09000064804f98c4
FDA-1996-P-0309-0002 FDA Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 Acknowledgement Letter to Andes Candies Inc Nutrtion Reseach Group Other Acknowledgement Letter/Receipt 1996-01-29T05:00:00Z 1996 1 2014-02-20T05:00:00Z   2014-02-20T11:57:46Z   0 0 090000648122e0c8
FDA-1996-P-0309-0001 FDA Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 Citizen Petition from Andes Candies, Inc., Nutrition Research Group (NRG) Other Citizen Petition 1996-01-29T05:00:00Z 1996 1 1996-01-29T05:00:00Z   2024-11-12T04:12:58Z   1 0 0900006480504c67
FDA-1995-N-0062-0003 FDA Quality/fill container; common or unusual name regulations-OPEN FDA-1995-N-0062 Answer Letter from FDA/Associate Commissioner for Legislative Affairs to Comment from The Honorable Patty Murray, Unites States Senate Other Answer 1996-01-23T05:00:00Z 1996 1     2020-01-09T15:14:52Z   0 0 090000648056c8f0

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);